Home › Kidney Cancer (Renal Cell Carcinoma) › Colorado › Fort Collins
Kidney Cancer (Renal Cell Carcinoma) clinical trials in Fort Collins, CO
3 studies for Kidney Cancer (Renal Cell Carcinoma) are looking for participants at sites in and around Fort Collins (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Poudre Valley Hospital, Fort Collins
- Cancer Care and Hematology-Fort Collins, Fort Collins
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
RecruitingPhase 2
- Poudre Valley Hospital, Fort Collins
- Cancer Care and Hematology-Fort Collins, Fort Collins
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
RecruitingPhase 3
- Poudre Valley Hospital, Fort Collins
- Cancer Care and Hematology-Fort Collins, Fort Collins
Kidney Cancer (Renal Cell Carcinoma) trials in other cities
- Houston, TX35 studies
- New York City, NY27 studies
- Nashville, TN23 studies
- Dallas, TX23 studies
- St. Louis, MO23 studies
- Los Angeles, CA20 studies
- Boston, MA16 studies
- Baldwin Park, CA16 studies
- Philadelphia, PA15 studies
- Pittsburgh, PA15 studies
- Queens, NY15 studies
- Rochester, MN14 studies
Other studies in Fort Collins
- Lung Cancer8 studies
- Breast Cancer6 studies
- Non-Small Cell Lung Cancer6 studies
- Prostate Cancer6 studies
- Ovarian Cancer5 studies
- Cancer (all types)4 studies
- Bladder Cancer4 studies
- Colon Cancer4 studies
- Metastatic Cancer3 studies
- Metabolic Disorders3 studies
- Insulin Resistance3 studies
- Multiple Myeloma3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.